Cefobid Related Published Studies
Well-designed clinical trials related to Cefobid (Cefoperazone)
Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors. [2011.05]
Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers. [2008.11]
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India. [2008.06]
Well-designed clinical trials possibly related to Cefobid (Cefoperazone)
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli. [2006.12]
Other research related to Cefobid (Cefoperazone)
Randomized comparison of piperacillin-tazobactam plus amikacin versus
cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in
children with lymphoma and solid tumors. [2013]
Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum Beta-lactamase detection method as well as the polymerase chain reaction method. [2011.07.01]
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible acinetobacter baumannii strains]. [2011.07]
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia. [2011.06.14]
Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows. [2010.09]
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone. [2010.08]
[Cefoperazone/sulbactam in continuous infusion]. [2010.04]
A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone). [2009.12]
Cefoperazone induced gastro-intestinal haemorrhage. A case report. [2008.11]
Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting. [2008.03]
A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis. [2008.01]
Voltammetric studies on the antibiotic drug cefoperazone quantification and pharmacokinetic studies. [2006.10.11]
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia. [2006.02.28]
Severe INR elevation in a patient with choledocholithiasis receiving cefoperazone. [2006]
Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia. [2006]
[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children] [2005.09]
Other possibly related research studies
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa] [2006.02]
[Molecular mechanism of multiple-drug and pan-drug resistance among Acinetobacter species] [2006.01.03]
Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. [2007.01]
Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). [2006.06]
Salmonella group C necrotizing fasciitis: a case report and review of the literature. [2006.04]
[A case of anaphylactic shock due to an antibiotic used preoperatively] [2005.10]
[Microbiological isolates in patients with febrile neutropenia and hematological neoplasias] [2006.09]
[Bacteria isolated from pleural fluid and their resistance to antimicrobials] [2006.04]
Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam. [2006.11]
Potential of antimicrobial agents to inhibit fungi to aid isolation of Campylobacter. [2006.09]
Short communication: antimicrobial drug susceptibility of Staphylococcus aureus from subclinical bovine mastitis in Italy. [2006.08]
Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup. [2005.06]
Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. [2006.04]
Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae. [2005.07]
Multiple antimicrobial resistant Salmonella enterica serovar Paratyphi B variant Java in cattle: a case report. [2005.03.12]
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data. [2007.02]
The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups. [2007]
[Incidence and resistance patterns of pathogens from lower respiratory tract infections (LRTI)] [2007.01]
Diversity of Campylobacter coli genotypes in the lower porcine gastrointestinal tract at time of slaughter. [2007.10.08]
[Allergic airway response associated with the intestinal microflora disruption induced by antibiotic therapy] [2007.06]
[Erysipelothrix rhusiopathiae endocarditis] [2006.07]
Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa. [2007.06]
Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia. [2007.08]
Diversity of Campylobacter coli genotypes in the lower porcine gastrointestinal tract at time of slaughter. [2007.12]
Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia. [2007.10]
Current pattern of enteric fever: a prospective clinical and microbiological study. [2007.10]
Sulbactam-containing beta-lactamase inhibitor combinations. [2008.01]
[Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005] [2007.10.23]
[Analysis of the molecular epidemiology and distribution of pathogenic bacteria in burn wards of Ruijin Hospital from 2004 to 2006] [2009.04]
Prospective evaluation of the efficacy of antibiotic prophylaxis before cystoscopy. [2009.04]
Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. [2009.08]
[Effects of antimicrobial agents on the Toll like receptors and myeloid differentiation protein-2 in liver tissue of alcohol-induced liver disease: experiment with rats] [2009.01.13]
Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. [2009.05]
[Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy: a case report] [2008.12]
The utilization of antibiotics in the management of acute pancreatitis--experience from one transitional country university hospital. [2008.12]
[A rare cause of nosocomial bacteremia: Sphingomonas paucimobilis] [2008.10]
[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study] [2008.10]
Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis. [2009.02]
[Changes in the plasma levels of endotoxin in severe burn patients under the treatment of antibiotics] [2008.04]
[Following-up of nosocomial lower respiratory infection in patients with hematological malignancy after chemotherapy] [2008.02]
Salmonella typhi sepsis and rhabdomyolysis with acute renal failure: a rare presentation of a common disease. [2010.07]
False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. [2010.07]
[Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit] [2009.10]
Emergence of resistance to third-generation cephalosporin in Shigella--a case report. [2010.08]
Multidrug-resistant Gram-negative bacteria in postoperative infections. [2009.03]
Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. [2009.05.01]
A study of the chemiluminescence behavior of cephalosporins with luminol and its analytical application. [2009.08]
[A community acquired pneumonia case caused by Ralstonia pickettii] [2009.04]
Antibiotic prophylaxis tailored to local organisms reduces percutaneous gastrostomy site infection. [2009.05]
[Factors influencing the use of systemic antibiotics in hospitalized pediatric patients in Bucharest, Romania] [2009.01]
[Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection] [2008.11]
[Analysis of antibiotic consumption and microorganism resistance changes] [2008]
bla(CTX-M), bla(TEM), and bla(SHV) in Enterobacteriaceae from North-Indian tertiary hospital: high occurrence of combination genes. [2011.02]
Time trends in the epidemiology of microbial infections at a tertiary care center in west India over last 5 years. [2010.12]
Endovascular repair and pharmacotherapy of an inflammatory abdominal aortic aneurysm complicated by primary aortoduodenal fistula. [2011.05]
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. [2011.02]
[Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE]. [2010.11]
Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus? [2010.12]
Effects of legal antibiotic restrictions on consumption of broad-spectrum beta-lactam antibiotics, glycopeptides and amphotericin B. [2010]
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? [2011.01]
Antimicrobial susceptibility of Bordetella bronchiseptica isolates from pigs with respiratory diseases on farms in China. [2011.01]
Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008. [2010]
Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients. [2011.01]
Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. [2010.10]
[Treatment of critically ill influenza A H1N1 patients in plateau region]. [2010.03]
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention]. [2010.02]
Dynamic expressions of liver tissue apoptosis-related genes of Vibrio vulnificus sepsis rats and the effects of antibacterial agents. [2009.04]
|